Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Iron overload
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Pathophysiology== Defects in iron metabolism, specifically involving the iron regulatory protein [[hepcidin]] are thought to play an integral role in the pathogenesis of hereditary hemochromatosis.<ref name="NEJM Olynyk">{{cite journal |last1=Olynyk |first1=John K. |last2=Ramm |first2=Grant A. |title=Hemochromatosis |journal=New England Journal of Medicine |date=8 December 2022 |volume=387 |issue=23 |pages=2159β70 |doi=10.1056/NEJMra2119758|pmid=36477033 |s2cid=254432917 }}</ref> Normally, hepcidin acts to reduce iron levels in the body by inhibiting intestinal iron absorption and inhibiting iron mobilization from stores in the [[bone marrow]] and [[liver]].<ref name="NEJM Olynyk" /> Iron is absorbed from the intestines (mostly in the [[duodenum]]) and transported across intestinal [[enterocyte]]s or mobilized out of storage in liver [[hepatocyte]]s or from [[macrophage]]s in the bone marrow by the transmembrane [[ferroportin]] transporter.<ref name="NEJM Olynyk" /> In response to elevated plasma iron levels, hepcidin inhibits the ferroportin transporter leading to decreased iron mobilization from stores and decreased intestinal iron absorption, thus functioning as a negative iron regulatory protein.<ref name="NEJM Olynyk" /> In hereditary hemochromatosis, mutations in the proteins involved in hepcidin production including [[HFE (gene)|HFE (homeostatic iron regulator)]], [[hemojuvelin]] and [[transferrin receptor 2]] lead to a loss or decrease in hepcidin production, which subsequently leads to the loss of the inhibitory signal regulating iron absorption and mobilization and thus leads to iron overload.<ref name="NEJM Olynyk" /> In very rare instances, mutations in ferroportin result in ferroportin resistance to hepcidin's negative regulatory effects, and continued intestinal iron absorption and mobilization despite inhibitory signaling from hepcidin.<ref name="NEJM Olynyk" /> The resulting iron overload causes iron to deposit in various sites throughout the body, especially the liver and joints, which coupled with [[oxidative stress]] leads to organ damage or joint damage and the pathological findings seen in hemochromatosis.<ref name="NEJM Olynyk" />
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)